Clinical Trial Update: Treatment of Patients With Newly Onset of Type 1 Diabetes With Mesenchymal Stem Cells [NA]

View source ↗

Summary

A completed clinical trial investigated the use of mesenchymal stem cells for newly diagnosed Type 1 diabetes; no efficacy results are provided in the summary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: Uppsala University Hospital | Conditions: Type 1 Diabetes | NA | Status: COMPLETED